Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.26
+0.08 (1.11%)
At close: Jan 17, 2025, 4:00 PM
7.68
+0.42 (5.79%)
Pre-market: Jan 21, 2025, 8:40 AM EST
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $564.56 million as of January 21, 2025. Its market cap has decreased by -49.52% in one year.
Market Cap
564.56M
Enterprise Value
125.90M
1-Year Change
-49.52%
Ranking
Category
Stock Price
$7.26
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $564.56M, an increase of 396.54%. That is a compound annual growth rate of 19.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 564.60M | -16.64% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |